BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12698564)

  • 1. [Study of functional activity of components and factors of the human complement system].
    Kozlov LV
    Vopr Med Khim; 2002; 48(6):624-31. PubMed ID: 12698564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naïve patients.
    Varga L; Széplaki G; Visy B; Füst G; Harmat G; Miklós K; Németh J; Cervenak L; Karádi I; Farkas H
    Mol Immunol; 2007 Feb; 44(6):1454-60. PubMed ID: 16750855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C1 inhibitor, C3 activator, IgG, IgA, and IgM titers in Nigerian sickle cell disease patients with plasmodium falciparum.
    Arinola G; Ezeh C
    Iran J Immunol; 2007 Mar; 4(1):44-9. PubMed ID: 17652843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isotyping of human C4 complement using differences in the functional activity of C4A and C4B isotypes].
    Kozlov LV; Lakhtin VM; Skorokhodova TG; Batalova TN; Shoĭbonov BB; D'iakov VL; Guzova VA; Matveevskaia NS
    Bioorg Khim; 2000 Jul; 26(7):539-47. PubMed ID: 11008645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phylogeny of complement components in non-human primates.
    Schur PH; Connelly A; Jones TC
    J Immunol; 1975 Jan; 114(1 Pt 2):270-3. PubMed ID: 803999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement and IgG subclasses in agammaglobulinemic patients.
    Grumach AS; Kirschfink M
    Exp Clin Immunogenet; 1995; 12(1):10-5. PubMed ID: 7710760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of proteinase activity of complement system by immunoenzyme methods].
    Romanov SV; Kozlov LV; D'iakov VL; Batalova TN; Guzova VA
    Biomed Khim; 2003; 49(6):604-12. PubMed ID: 16119089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Levels of complement components in plasma of onco-hematologic patients with defective hemopoiesis].
    Rybakova LP; Tiagotin IV; Ganapiev AA; Moiseev SI; Ushakova EA; Abdulkadyrov KM; Ishchenko AM
    Vopr Onkol; 1996; 42(2):63-7. PubMed ID: 8815636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Determination of the functional activity, amount of C1 inhibitor, and autoantibodies as a tool for differential diagnosis of angioedema].
    Andina SS; Kozlov LV; D'iakov VL
    Biomed Khim; 2004; 50(1):86-91. PubMed ID: 15108631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of formation of complement C5-convertase].
    Kozlov LV; Lebedeva TV
    Bioorg Khim; 1998 May; 24(5):350-5. PubMed ID: 9661788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of binding of activated compliment component C4b with its target].
    Kozlov LV; Lakhtin VM; Skorokhodova TG; Batalova TN; Shoĭbonov BB; D'iakov VL; Guzova VA; Matveevskaia NS
    Bioorg Khim; 2000 Nov; 26(11):817-24. PubMed ID: 11696892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional studies in C1q deficiency.
    Chapuis RM; Hauptmann G; Grosshans E; Isliker H
    J Immunol; 1982 Oct; 129(4):1509-12. PubMed ID: 6980939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complement system in sclera.
    Brawman-Mintzer O; Mondino BJ; Mayer FJ
    Invest Ophthalmol Vis Sci; 1988 Nov; 29(11):1756-8. PubMed ID: 3182209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement and complement regulatory proteins in human tears.
    Willcox MD; Morris CA; Thakur A; Sack RA; Wickson J; Boey W
    Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):1-8. PubMed ID: 9008624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the complement system. General principles and perspectives].
    Julen N; Dauchel H; Lemercier C; Daveau M; Fontaine M; Sauger F; Maitrot B; Ripoche J
    Ann Biol Clin (Paris); 1990; 48(6):349-60. PubMed ID: 2221493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoglobulins and complement components in patients with lung cancer.
    Oner F; Savaş I; Numanoğlu N
    Tuberk Toraks; 2004; 52(1):19-23. PubMed ID: 15143368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement as a predictor of further miscarriage in couples with recurrent miscarriages.
    Sugiura-Ogasawara M; Nozawa K; Nakanishi T; Hattori Y; Ozaki Y
    Hum Reprod; 2006 Oct; 21(10):2711-4. PubMed ID: 16790609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological study in sickle cell disease patients: importance of the complement system].
    Sassi F; Bardi R; Neji T; Ayed K; Ben Dridi MF
    Tunis Med; 2003 Mar; 81(3):195-9. PubMed ID: 12793071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of C1 inhibitor by glycosaminoglycans: dextran sulfate species are effective inhibitors of in vitro complement activation in plasma.
    Wuillemin WA; te Velthuis H; Lubbers YT; de Ruig CP; Eldering E; Hack CE
    J Immunol; 1997 Aug; 159(4):1953-60. PubMed ID: 9257861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.